Description
An active metabolite of cholesterol; formed when cholesterol is metabolized by CYP27A1; decreases Aβ42 (EC50 = 250 nM) and increases Aβ38 levels with no effect on total Aβ in CHO2B7 cells; decreases endogenous murine Aβ42 production (60% and 75% decrease at concentrations of 3 and 10 μM, respectively)
Formal name: (3β)-3-hydroxy-cholest-5-en-26-oic acid
Synonyms: 3β-hydroxy-5-CA|Cholesterol-26-carboxylic Acid
Molecular weight: 416.6
CAS: 6561-58-6
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Sterol Lipids||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease||Research Area|Toxicology|Drug Metabolism|Cytochrome P450||Research Area|Toxicology|Drug Metabolism|Drug Metabolites